All News
Filter News
Found 553,247 articles
-
The plaintiffs allege that Gilead and other companies used anticompetitive tactics to keep prices artificially high for their respective HIV treatments.
-
A bacteriophage is a virus that infects bacteria. They aren’t typically used to treat bacterial infections, but in desperate cases, they have been used to treat particularly antibiotic-resistant infections.
-
The combination of Venclexta and Gazyva was rapidly approved by the FDA under a pilot program.
-
Agios Pharmaceuticals, headquartered in Cambridge, Mass., announced that its Tibsovo (ivosidenib) hit its primary endpoint in the Phase III ClarIDHy trial in patients with cholangiocarcinoma with an isocitrate dehydrogenase 1 (IDH1) mutation.
-
The trial evaluated margetuximab in patients with HER2-positive metastastic breast cancer who had already been treated with anti-HER2-targeted therapies.
-
Financial terms of the deal were not disclosed, but Genentech aims to use Parvus' technology to target IBD and Celiac.
-
BioSpace Global Roundup, May 16
5/16/2019
Pharma and biotech companies from across the globe provide business and pipeline updates, with news from Gecko, ValGenesis, NeuClone, Zymeworks, and more. -
The Institute of Cancer Research (ICR) in London, UK, is investing an initial £75 million to create a global center in what it is calling anti-evolution therapies for cancer.
-
Ginkgo Bioworks bought Warp Drive Bio’s genome mining platform, which includes its genome mining team, technology and database.
-
GeoVax Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11
5/16/2019
Recognizing the Support of the National Institutes of Health and the
-
Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases
5/16/2019
FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons
-
HKTDC Medical and Healthcare Fair finishes three-day run
5/16/2019
More than 12,000 buyers visit 2019 fair, up 8% on last year
-
Eisai to Present Data on Oncology Pipeline and Products at 55th ASCO Annual Meeting
5/16/2019
Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates regarding its in-house discovered lenvatinib mesylate, eribulin mesylate, and MORAb-202 will be given at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago, the United States, from May 31 to June 4, 2019.
-
Pharming Today Celebrates “hae day :-)” – the Global Awareness Day for Hereditary Angioedema, a Rare Life-threatening Condition
5/16/2019
Pharming Group N.V. today supports world “hae day :-)”.
-
Bittium Exhibits Its Products and Solutions for Neurophysiology at Post Cardiac Arrest Care 2019
5/16/2019
Bittium exhibits its products and solutions for neurophysiology at Post Cardiac Arrest Care 2019
-
Medidata recognised as a 2019 UK Great Place to Work®
5/16/2019
Company scores high for having a culture of diversity & belonging and work-life balance
-
Atriva Therapeutics Starts Clinical Development of Novel Host-Targeting Antiviral ATR-002 Against Influenza
5/16/2019
Phase I clinical trial to evaluate safety and tolerability of ATR-002 in healthy volunteers
-
Probiodrug Reports First Quarter 2019 Business Update
5/16/2019
Probiodrug AG announced today its first quarter business update for the period ending March 31, 2019.
-
Pharming Group Reports Interim Financial Results for the First Quarter of 2019
5/16/2019
Pharming Group N.V. presents its (unaudited) interim financial report for the first quarter ended 31 March 2019.
-
Teijin Establishes Nutraceutical Product Firm for Productive Aging
5/16/2019
Teijin Limited announced today its establishment of NOMON, Co., Ltd. to sell nutraceutical food and beverages that are scientifically proven to help people maintain their health.